{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-314249","form_type":"8-K","ticker":"DYN","cik":"0001818794","company_name":"Dyne Therapeutics, Inc.","filed_at":"2025-12-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.584904+00:00","generated_at":"2026-05-16T13:39:54.594724+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Dyne Therapeutics prices upsized $350M public offering at $18.44/share","bullets":["Priced 18,980,478 shares at $18.44/share; gross proceeds $350M.","Underwriters granted 30-day option for additional 2,847,071 shares.","Net proceeds estimated at ~$328.5M ($377.9M if option exercised).","Also borrowed $50M second tranche under Hercules Loan Agreement.","Cash runway extended into Q1 2028 with combined resources."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-314249","json":"https://secwatch.observer/filing/0001193125-25-314249.json","markdown":"https://secwatch.observer/filing/0001193125-25-314249.md","text":"https://secwatch.observer/filing/0001193125-25-314249.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818794/000119312525314249/0001193125-25-314249-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818794/000119312525314249/d76666d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:39:54.594724+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}